Mediation of alopecia areata by cooperation between CD4+ and CD8+ T lymphocytes -: Transfer to human scalp explants on Prkdcscid mice

被引:76
作者
Gilhar, A
Landau, M
Assy, B
Shalaginov, R
Serafimovich, S
Kalish, RS
机构
[1] Technion Israel Inst Technol, Fac Med, Lab Skin Res, IL-31096 Haifa, Israel
[2] Technion Israel Inst Technol, Flieman Med Ctr, Skin Res Labs, Haifa, Israel
[3] Elias Sourasky Med Ctr, Dept Dermatol, Tel Aviv, Israel
[4] SUNY Stony Brook, Dept Dermatol, Stony Brook, NY 11794 USA
关键词
D O I
10.1001/archderm.138.7.916
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Objective: To determine the role of CD4(+) and CD8(+) T lymphocytes in the pathogenesis of alopecia areata. Design: Relapse of alopecia areata was induced in autologous human scalp grafts on Prkdc(scid) mice by injection of activated T lymphocytes derived from lesional skin. CD4(+) and CD8(+) T cells were separated by magnetic beads before injection. Setting: University-based dermatology practice Participants: Eleven patients with either alopecia totalis or severe alopecia areata. Main Outcome Measures: Hair regrowth, hair loss, and immunohistochemical findings of scalp explants. Intervention: Transfer of scalp T cells to autologous lesional scalp explants on Prkdc(scid) mice. Results: Injection of unseparated T cells and mixed CD4(+) plus CD8(+) T cells resulted in significant hair loss (P<.01) in 5 of 5 experiments. However, injection of purified CD4(+) or CD8(+) T cells alone did not result in reproducible hair loss. CD4(+) and CD8(+) T cells induced follicular expression of intercellular adhesion molecule 1 (CD54), HLA-DR, and HLA-A, HLA-B, and HLA-C after injection into scalp grafts. Conclusions: CD4(+) and CD8(+) T cells have a role in the pathogenesis of alopecia areata. It is hypothesized that CD8(+) T cells act as the effector cells, with CD4(+) T cell help. It is now necessary to look for HLA-A, HLA-B, and HLA-C associations with alopecia areata. Therapeutic manipulations that interfere with CD8(+) activity should be examined.
引用
收藏
页码:916 / 922
页数:7
相关论文
共 42 条
[1]   Role of cytotoxic T cells in chronic alopecia areata [J].
Bodemer, C ;
Peuchmaur, M ;
Fraitaig, S ;
Chatenoud, L ;
Brousse, N ;
de Prost, Y .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2000, 114 (01) :112-116
[2]   Contact hypersensitivity in MHC class II-deficient mice depends on CD8 T lymphocytes primed by immunostimulating Langerhans cells [J].
Bouloc, A ;
Cavani, A ;
Katz, SI .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1998, 111 (01) :44-49
[3]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[4]   ABNORMAL EXPRESSION OF CLASS-I AND CLASS-II MAJOR HISTOCOMPATIBILITY ANTIGENS IN ALOPECIA-AREATA - MODULATION BY TOPICAL IMMUNOTHERAPY [J].
BROCKER, EB ;
ECHTERNACHTHAPPLE, K ;
HAMM, H ;
HAPPLE, R .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1987, 88 (05) :564-568
[5]   The genetic basis of alopecia areata:: HLA associations with patchy alopecia areata versus alopecia totalis and alopecia universalis [J].
Colombe, BW ;
Lou, CD ;
Price, VH .
JOURNAL OF INVESTIGATIVE DERMATOLOGY SYMPOSIUM PROCEEDINGS, 1999, 4 (03) :216-219
[6]  
COLOMBE BW, 1995, J AM ACAD DERMATOL, V33, P757
[7]   LIFETIME PREVALENCE OF PSYCHIATRIC-DISORDERS IN PATIENTS WITH ALOPECIA-AREATA [J].
COLON, EA ;
POPKIN, MK ;
CALLIES, AL ;
DESSERT, NJ ;
HORDINSKY, MK .
COMPREHENSIVE PSYCHIATRY, 1991, 32 (03) :245-251
[8]   Autoimmune hair loss (alopecia areata) transferred by T lymphocytes to human scalp explants on SCID mice [J].
Gilhar, A ;
Ullmann, Y ;
Berkutzki, T ;
Assy, B ;
Kalish, RS .
JOURNAL OF CLINICAL INVESTIGATION, 1998, 101 (01) :62-67
[9]   HAIR-GROWTH IN SCALP GRAFTS FROM PATIENTS WITH ALOPECIA-AREATA AND ALOPECIA UNIVERSALIS GRAFTED ONTO NUDE-MICE [J].
GILHAR, A ;
KRUEGER, GG .
ARCHIVES OF DERMATOLOGY, 1987, 123 (01) :44-50
[10]   FAILURE OF PASSIVE TRANSFER OF SERUM FROM PATIENTS WITH ALOPECIA-AREATA AND ALOPECIA UNIVERSALIS TO INHIBIT HAIR-GROWTH IN TRANSPLANTS OF HUMAN SCALP SKIN GRAFTED ON TO NUDE-MICE [J].
GILHAR, A ;
PILLAR, T ;
ASSAY, B ;
DAVID, M .
BRITISH JOURNAL OF DERMATOLOGY, 1992, 126 (02) :166-171